<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Background </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C0033845" disease_type="Disease or Syndrome" abbrv="">Pseudotumor cerebri</z:e> is an acknowledged but unusual complication of oral <z:chebi fb="1" ids="50694">minocycline</z:chebi> use </plain></SENT>
<SENT sid="2" pm="."><plain><z:e sem="disease" ids="C0456909" disease_type="Disease or Syndrome" abbrv="">Vision loss</z:e> and <z:hpo ids='HP_0001085'>papilledema</z:hpo> have been described as mild and transient, and some authors suggest that treatment is not needed </plain></SENT>
<SENT sid="3" pm="."><plain>Methods </plain></SENT>
<SENT sid="4" pm="."><plain>Case series of 2 patients with severe <z:hpo ids='HP_0001085'>papilledema</z:hpo> and visual field loss </plain></SENT>
<SENT sid="5" pm="."><plain>Results </plain></SENT>
<SENT sid="6" pm="."><plain>Severe <z:e sem="disease" ids="C0033845" disease_type="Disease or Syndrome" abbrv="">pseudotumor cerebri</z:e> developed in 2 nonobese patients taking <z:chebi fb="1" ids="50694">minocycline</z:chebi> </plain></SENT>
<SENT sid="7" pm="."><plain>Their disease required further treatment even upon drug discontinuation because of visual field loss and <z:hpo ids='HP_0001085'>papilledema</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>Conclusions </plain></SENT>
<SENT sid="9" pm="."><plain><z:chebi fb="1" ids="50694">Minocycline</z:chebi>-associated <z:e sem="disease" ids="C0033845" disease_type="Disease or Syndrome" abbrv="">pseudotumor cerebri</z:e> is not always a self-limited condition and may require aggressive medical or surgical management </plain></SENT>
</text></document>